Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Current Status and Future Perspectives on Therapeutic Potential of Apigenin: Focus on Metabolic-Syndrome-Dependent Organ Dysfunction
Waqas Alam, Carmine Rocca, Haroon Khan, et al.
Antioxidants (2021) Vol. 10, Iss. 10, pp. 1643-1643
Open Access | Times Cited: 33

Showing 1-25 of 33 citing articles:

Pharmacological and Molecular Insight on the Cardioprotective Role of Apigenin
Shilu Deepa Thomas, Niraj Kumar Jha, Saurabh Kumar Jha, et al.
Nutrients (2023) Vol. 15, Iss. 2, pp. 385-385
Open Access | Times Cited: 50
Harnessing the Power of Polyphenols: A New Frontier in Disease Prevention and Therapy
Mohamed El Oirdi
Pharmaceuticals (2024) Vol. 17, Iss. 6, pp. 692-692
Open Access | Times Cited: 20
How Curcumin Targets Inflammatory Mediators in Diabetes: Therapeutic Insights and Possible Solutions
Yaseen Hussain, Haroon Khan, Ghallab Alotaibi, et al.
Molecules (2022) Vol. 27, Iss. 13, pp. 4058-4058
Open Access | Times Cited: 41
Potential Synergistic Supplementation of NAD+ Promoting Compounds as a Strategy for Increasing Healthspan
Arastu Sharma, Sophie Chabloz, Rebecca A. Lapides, et al.
Nutrients (2023) Vol. 15, Iss. 2, pp. 445-445
Open Access | Times Cited: 30
Potential Benefits of Antioxidant Phytochemicals in Type 2 Diabetes
Arman Arabshomali, Shadi Bazzazzadehgan, Fakhri Mahdi, et al.
Molecules (2023) Vol. 28, Iss. 20, pp. 7209-7209
Open Access | Times Cited: 28
Dietary Antioxidants and Chronic Diseases
Małgorzata Elżbieta Zujko, Anna Maria Witkowska
Antioxidants (2023) Vol. 12, Iss. 2, pp. 362-362
Open Access | Times Cited: 25
Bioactivity and mechanisms of flavonoids in decreasing insulin resistance
Min Zhou, William H. Konigsberg, Canhua Hao, et al.
Journal of Enzyme Inhibition and Medicinal Chemistry (2023) Vol. 38, Iss. 1
Open Access | Times Cited: 25
Antioxidant, Anti-Inflammatory, Anti-Diabetic, and Pro-Osteogenic Activities of Polyphenols for the Treatment of Two Different Chronic Diseases: Type 2 Diabetes Mellitus and Osteoporosis
Emanuele Salvatore Scarpa, A. Antonelli, Giancarlo Balercia, et al.
Biomolecules (2024) Vol. 14, Iss. 7, pp. 836-836
Open Access | Times Cited: 16
A comprehensive review of apigenin a dietary flavonoid: biological sources, nutraceutical prospects, chemistry and pharmacological insights and health benefits
Abhinav Pratap Singh, Jagjit Singh, Gulistan Parween, et al.
Critical Reviews in Food Science and Nutrition (2024), pp. 1-37
Closed Access | Times Cited: 15
Bio-Actives from Natural Products with Potential Cardioprotective Properties: Isolation, Identification, and Pharmacological Actions of Apigenin, Quercetin, and Silibinin
Ekaterina‐Michaela Tomou, Paraskevi Papakyriakopoulou, Helen Skaltsa, et al.
Molecules (2023) Vol. 28, Iss. 5, pp. 2387-2387
Open Access | Times Cited: 23
Dissolution and antioxidant potential of apigenin self nanoemulsifying drug delivery system (SNEDDS) for oral delivery
Boontida Morakul, Veerawat Teeranachaideekul, Waree Limwikrant, et al.
Scientific Reports (2024) Vol. 14, Iss. 1
Open Access | Times Cited: 6
Protective Action Mechanisms of Launaea mucronata Extract and Its Nano-Formulation against Nephrotoxicity in Rats as Revealed via Biochemical, Histopathological, and UPLC-QTOF–MS/MS Analyses
Amany A. El-Fadaly, Inas Y. Younis, Mohamed F. Abdelhameed, et al.
Metabolites (2023) Vol. 13, Iss. 7, pp. 786-786
Open Access | Times Cited: 13
Apigenin Alleviates Autistic-like Stereotyped Repetitive Behaviors and Mitigates Brain Oxidative Stress in Mice
Petrilla Jayaprakash, Dmytro Isaev, Keun‐Hang Susan Yang, et al.
Pharmaceuticals (2024) Vol. 17, Iss. 4, pp. 482-482
Open Access | Times Cited: 4
Exploration of natural flavones’ bioactivity and bioavailability in chronic inflammation induced-type-2 diabetes mellitus
Lingchao Miao, Conghui Liu, Meang Sam Cheong, et al.
Critical Reviews in Food Science and Nutrition (2022) Vol. 63, Iss. 33, pp. 11640-11667
Closed Access | Times Cited: 18
Advances in Leaf Plant Bioactive Compounds: Modulation of Chronic Inflammation Related to Obesity
Jorge Gomes Lopes Barros, Ana S. Abraão, Irene Gouvinhas, et al.
International Journal of Molecular Sciences (2025) Vol. 26, Iss. 7, pp. 3358-3358
Open Access
The influence of apigenin on cellular responses to radiation: From protection to sensitization
Taha Monadi, Zahra Mohajer, Afsaneh Soltani, et al.
BioFactors (2024)
Closed Access | Times Cited: 3
Exploring beetroot (Beta vulgaris L.) for diabetes mellitus and Alzheimer's disease dual therapy: in vitro and computational studies
Oluwafemi Adeleke Ojo, Gideon Ampoma Gyebi, Emmanuel Henry Ezenabor, et al.
RSC Advances (2024) Vol. 14, Iss. 27, pp. 19362-19380
Open Access | Times Cited: 2
Dietary apigenin ameliorates obesity-related hypertension through TRPV4-dependent vasorelaxation and TRPV4-independent adiponectin secretion
Aidi Mou, Fang Sun, Dan Tong, et al.
Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease (2024) Vol. 1870, Iss. 8, pp. 167488-167488
Open Access | Times Cited: 2
Monophosphate Derivatives of Luteolin and Apigenin as Efficient Precursors with Improved Oral Bioavailability in Rats
Shih‐Hsiung Wu, Shang‐Ta Wang, Guan‐Yuan Chen, et al.
Antioxidants (2024) Vol. 13, Iss. 12, pp. 1530-1530
Open Access | Times Cited: 2
Quercetin and Its Derivative Counteract Palmitate-Dependent Lipotoxicity by Inhibiting Oxidative Stress and Inflammation in Cardiomyocytes
Maria Concetta Granieri, Carmine Rocca, Anna De Bartolo, et al.
International Journal of Environmental Research and Public Health (2023) Vol. 20, Iss. 4, pp. 3492-3492
Open Access | Times Cited: 6
The molecular genetics of PI3K/PTEN/AKT/mTOR pathway in the malformations of cortical development
Qing Ma, Guang Chen, Ying Li, et al.
Genes & Diseases (2023) Vol. 11, Iss. 5, pp. 101021-101021
Open Access | Times Cited: 6
Apigenin’s Health Benefits in Kidney Disease: Pharmacological Insights and Future Perspectives
Jiabin Wu, Wei Dai, Ke Li, et al.
Food Reviews International (2024), pp. 1-29
Closed Access | Times Cited: 2
Apigenin attenuates high-fat diet-induced nephropathy in rats by hypoglycemic and hypolipidemic effects, and concomitant activation of the Nrf2/antioxidant axis
Tahany Saleh Aldayel
Journal of Functional Foods (2022) Vol. 99, pp. 105295-105295
Open Access | Times Cited: 10
Genetic and therapeutic for oral lichen planus and diabetes mellitus: a comprehensive study
Manman Yao, Ying-Chun Lu, Tiejun Liu, et al.
BMC Oral Health (2024) Vol. 24, Iss. 1
Open Access | Times Cited: 1
Apigenin as a Promising Agent for Enhancing Female Reproductive Function and Treating Associated Disorders
Alexander V. Sirotkin, Abdel Halim Harrath
Biomedicines (2024) Vol. 12, Iss. 10, pp. 2405-2405
Open Access | Times Cited: 1
Page 1 - Next Page

Scroll to top